Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FWUVM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $29,670
Award facts
- Contract value 100% obligated
- $29,669.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 7, 2025, the Defense Logistics Agency awarded a delivery order valued at $29,669.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, was issued without set-aside designation. The delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA under the SPE2DB program, a single-award contract valued at $499,999,999 through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a significant supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The company's federal contract portfolio demonstrates expertise across diverse medical product categories, including specialty medications, injections, and oncology treatments. As a registered woman-owned small business since 2001, the company continues to leverage its status to compete effectively in federal procurement markets while maintaining a robust delivery record for the Defense Logistics Agency's medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FWUVM?
SPE2DB25FWUVM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FWUVM worth?
The government has obligated $29,670 on SPE2DB25FWUVM.
Is contract SPE2DB25FWUVM an order under another contract?
Yes. SPE2DB25FWUVM is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUVM competed?
The extent of competition for SPE2DB25FWUVM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award